Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer drugs. Its structural features enable selective binding to enzyme active sites, making it valuable in targeted therapies. Commonly employed in pharmaceutical research for compounds aimed at treating chronic myeloid leukemia and other tyrosine kinase-driven diseases. Also utilized in the preparation of peptide-like molecules with enhanced metabolic stability and bioavailability.